{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:44:55Z","timestamp":1772120695884,"version":"3.50.1"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T00:00:00Z","timestamp":1650067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ebiom.2022.104036","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T23:11:20Z","timestamp":1651273880000},"page":"104036","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["A low dose adenovirus vectored vaccine expressing Schistosoma mansoni Cathepsin B protects from intestinal schistosomiasis in mice"],"prefix":"10.1016","volume":"80","author":[{"given":"Dilhan J.","family":"Perera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4092-7172","authenticated-orcid":false,"given":"Adam S.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4181-8637","authenticated-orcid":false,"given":"Sunny S.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyyed Mehdy","family":"Elahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Gadoury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risini D.","family":"Weeratna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9nald","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9012-4212","authenticated-orcid":false,"given":"Momar","family":"Ndao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2022.104036_bib0001","series-title":"Schistosomiasis","year":"2022"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104036_bib0002","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00281-020-00789-x","article-title":"Schistosomiasis-from immunopathology to vaccines","volume":"42","author":"McManus","year":"2020","journal-title":"Semin Immunopathol"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104036_bib0003","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02582-16","article-title":"Praziquantel for schistosomiasis: Single-drug metabolism revisited, mode of action, and resistance","volume":"61","author":"Vale","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104036_bib0004","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12879-016-1444-z","article-title":"A vaccine consisting of Schistosoma mansoni cathepsin B formulated in Montanide ISA 720 VG induces high level protection against murine schistosomiasis","volume":"16","author":"Ricciardi","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104036_bib0005","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.vaccine.2014.11.016","article-title":"Evaluation of the immune response and protective efficacy of Schistosoma mansoni Cathepsin B in mice using CpG dinucleotides as adjuvant","volume":"33","author":"Ricciardi","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2022.104036_bib0006","first-page":"2990","article-title":"Adjuvanted schistosoma mansoni-cathepsin b with sulfated lactosyl archaeol archaeosomes or AddaVaxTM provides protection in a pre-clinical schistosomiasis model","volume":"0","author":"Perera","year":"2020","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104036_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007490","article-title":"Vaccination against the digestive enzyme Cathepsin B using a YS1646 Salmonella enterica Typhimurium vector provides almost complete protection against Schistosoma mansoni challenge in a mouse model","volume":"13","author":"Hassan","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"issue":"39","key":"10.1016\/j.ebiom.2022.104036_bib0008","doi-asserted-by":"crossref","first-page":"5580","DOI":"10.1016\/j.vaccine.2021.08.031","article-title":"Therapeutic activity of a Salmonella-vectored Schistosoma mansoni vaccine in a mouse model of chronic infection","volume":"39","author":"Hassan","year":"2021","journal-title":"Vaccine"},{"issue":"10249","key":"10.1016\/j.ebiom.2022.104036_bib0009","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0140-6736(20)31605-6","article-title":"Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"396","author":"Zhu","year":"2020","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ebiom.2022.104036_bib0010","doi-asserted-by":"crossref","first-page":"e688","DOI":"10.1016\/S2352-3018(20)30229-0","article-title":"Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1\/2a study","volume":"7","author":"Baden","year":"2020","journal-title":"Lancet HIV"},{"issue":"10","key":"10.1016\/j.ebiom.2022.104036_bib0011","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1093\/cid\/ciz653","volume":"70","author":"Cicconi","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.ebiom.2022.104036_bib0012","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00262-015-1706-4","article-title":"Extended evaluation of a phase 1\/2 trial on dosing, safety, immunogenicity, and overall survival after immunizations with an advanced-generation Ad5 [E1-, E2b-]-CEA(6D) vaccine in late-stage colorectal cancer","volume":"64","author":"Balint","year":"2015","journal-title":"Cancer Immunol Immunother"},{"issue":"8","key":"10.1016\/j.ebiom.2022.104036_bib0013","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00262-013-1400-3","article-title":"Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients","volume":"62","author":"Morse","year":"2013","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.ebiom.2022.104036_bib0014","unstructured":"University Hospitals of North Midlands NHS Trust. Covid-19 Vaccine Response in Immunocompromised Haematology Patients (COVAC-IC). 2021 Mar 18 [last updated 2022 Mar 4]. In: ClinicalTrials.gov [Internet]. Bethesda (MD): U.S. National Library of Medicine. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04805216?term=BNT162b2&cond=immunocompromised&draw=2 Identifier: NCT04805216."},{"issue":"9","key":"10.1016\/j.ebiom.2022.104036_bib0015","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/cgt.2009.17","article-title":"Optimization of vaccine responses with an E1, E2b and E3-deleted Ad5 vector circumvents pre-existing anti-vector immunity","volume":"16","author":"Osada","year":"2009","journal-title":"Cancer Gene Ther"},{"issue":"205","key":"10.1016\/j.ebiom.2022.104036_bib0016","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006843","article-title":"A human type 5 adenovirus-based tuberculosis vaccine induces robust T cell responses in humans despite preexisting anti-adenovirus immunity","volume":"5","author":"Smaill","year":"2013","journal-title":"Sci Transl Med"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104036_bib0017","doi-asserted-by":"crossref","first-page":"711","DOI":"10.4269\/ajtmh.19-0494","article-title":"Interactions of Schistosoma and HIV in Sub-Saharan Africa: a systematic review","volume":"102","author":"Furch","year":"2020","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104036_bib0018","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/QAI.0000000000002536","article-title":"Schistosoma mansoni infection is associated with a higher probability of tuberculosis disease in HIV-infected adults in Kenya","volume":"86","author":"McLaughlin","year":"2021","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ebiom.2022.104036_bib0019","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/bs.apar.2015.12.003","article-title":"Coinfection of schistosoma species with hepatitis B or hepatitis C viruses","volume":"91","author":"Abruzzi","year":"2016","journal-title":"Adv Parasitol"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104036_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13104-015-1468-2","article-title":"Prevalence and clinical correlates of Schistosoma mansoni co-infection among malaria infected patients, Northwest Ethiopia","volume":"8","author":"Getie","year":"2015","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.ebiom.2022.104036_bib0021","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3389\/fimmu.2020.00127","article-title":"CD4 T cells in mycobacterium tuberculosis and Schistosoma mansoni co-infected individuals maintain functional TH1 responses","volume":"11","author":"McLaughlin","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104036_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-021-00356-x","article-title":"Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic","volume":"6","author":"Mendon\u00e7a","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.ebiom.2022.104036_bib0023","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ebiom.2019.04.029","article-title":"Phenotypic screening of nonsteroidal anti-inflammatory drugs identified mefenamic acid as a drug for the treatment of schistosomiasis","volume":"43","author":"Lago","year":"2019","journal-title":"eBioMedicine"},{"key":"10.1016\/j.ebiom.2022.104036_bib0024","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jviromet.2014.08.013","article-title":"Establishment and validation of new complementing cells for production of E1-deleted adenovirus vectors in serum-free suspension culture","volume":"208","author":"Gilbert","year":"2014","journal-title":"J Virol Methods"},{"issue":"47","key":"10.1016\/j.ebiom.2022.104036_bib0025","doi-asserted-by":"crossref","first-page":"7029","DOI":"10.1016\/j.vaccine.2019.08.079","article-title":"Evaluation of recombinant adenovirus vectors and adjuvanted protein as a heterologous prime-boost strategy using HER2 as a model antigen","volume":"37","author":"Haq","year":"2019","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104036_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6750-6-43","article-title":"The cumate gene-switch: a system for regulated expression in mammalian cells","volume":"6","author":"Mullick","year":"2006","journal-title":"BMC Biotechnol"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104036_bib0027","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1073\/pnas.95.5.2509","article-title":"A simplified system for generating recombinant adenoviruses","volume":"95","author":"He","year":"1998","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ebiom.2022.104036_bib0028","doi-asserted-by":"crossref","unstructured":"Oualikene W, Lamoureux L, Weber JM, Massie B. Protease-Deleted Adenovirus Vectors and Complementing Cell Lines: Potential Applications of Single-Round Replication Mutants for Vaccination and Gene Therapy. Human Gene Therapy. 2004;11(9):1341\u20131353. https:\/\/doi.org\/10.1089\/10430340050032438.","DOI":"10.1089\/10430340050032438"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104036_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007490","article-title":"Vaccination against the digestive enzyme Cathepsin B using a YS1646 Salmonella enterica Typhimurium vector provides almost complete protection against Schistosoma mansoni challenge in a mouse model","volume":"13","author":"Hassan","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"issue":"1\u20132","key":"10.1016\/j.ebiom.2022.104036_bib0030","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-1759(98)00170-7","article-title":"A statistically defined endpoint titer determination method for immunoassays","volume":"221","author":"Frey","year":"1998","journal-title":"J Immunol Methods"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104036_bib0031","doi-asserted-by":"crossref","first-page":"e0210009","DOI":"10.1371\/journal.pone.0210009","article-title":"A plant-derived VLP influenza vaccine elicits a balanced immune response even in very old mice with co-morbidities","volume":"14","author":"Hodgins","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104036_bib0032","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/cyto.a.21015","article-title":"SPICE: exploration and analysis of post-cytometric complex multivariate datasets","volume":"79A","author":"Roederer","year":"2011","journal-title":"Cytom Part A"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104036_bib0033","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/s41592-018-0215-8","article-title":"An explant technique for high-resolution imaging and manipulation of mycobacterial granulomas","volume":"15","author":"Cronan","year":"2018","journal-title":"Nat Methods"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104036_bib0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms6375","article-title":"Omega-1 knockdown in Schistosoma mansoni eggs by lentivirus transduction reduces granuloma size in vivo","volume":"5","author":"Hagen","year":"2014","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104036_bib0035","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4193\/Rhino16.215","article-title":"Periostin as a marker of mucosal remodelling in chronic rhinosinusitis","volume":"55","author":"Ebenezer","year":"2017","journal-title":"Rhinol J"},{"issue":"May","key":"10.1016\/j.ebiom.2022.104036_bib0036","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.3389\/fimmu.2019.01022","article-title":"Effect of cytotoxic T-lymphocyte antigen-4 on the efficacy of the fatty acid-binding protein vaccine against schistosoma japonicum","volume":"10","author":"Tang","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104036_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: Open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104036_bib0038","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav Res Methods"},{"issue":"8","key":"10.1016\/j.ebiom.2022.104036_bib0039","doi-asserted-by":"crossref","first-page":"e504","DOI":"10.1371\/journal.pntd.0000504","article-title":"Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni","volume":"3","author":"Melman","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104036_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243224","article-title":"A systematic review and meta-analysis on the rate of human schistosomiasis reinfection","volume":"15","author":"Zacharia","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2022.104036_bib0041","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3697216","article-title":"Prevalence and reinfection rates of schistosoma mansoni and praziquantel efficacy against the parasite among primary school children in Sanja Town, Northwest Ethiopia","author":"Woldegerima","year":"2019","journal-title":"J Parasitol Res"},{"issue":"7","key":"10.1016\/j.ebiom.2022.104036_bib0042","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.vaccine.2013.12.059","article-title":"Construction and evaluation of replication-defective recombinant optimized triosephosphate isomerase adenoviral vaccination in Schistosoma japonicum challenged mice","volume":"32","author":"Dai","year":"2014","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104036_bib0043","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120792","article-title":"Enhancement of protective efficacy through adenoviral vectored vaccine priming and protein boosting strategy encoding triosephosphate isomerase (SjTPI) against schistosoma japonicum in Mice","volume":"10","author":"Dai","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104036_bib0044","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085401","article-title":"Cysteine peptidases as schistosomiasis vaccines with inbuilt adjuvanticity","volume":"9","author":"El Ridi","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.ebiom.2022.104036_bib0045","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.vaccine.2015.12.032","article-title":"Workshop report: schistosomiasis vaccine clinical development and product characteristics","volume":"34","author":"Mo","year":"2016","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104036_bib0046","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-26497-0","article-title":"Rhesus macaques self-curing from a schistosome infection can display complete immunity to challenge","volume":"12","author":"Amaral","year":"2021","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104036_bib0047","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.4049\/jimmunol.137.12.3946","article-title":"IgM antibodies recognizing carbohydrate epitopes shared between schistosomula and miracidia of Schistosoma mansoni that block in vitro killing","volume":"137","author":"Yi","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.ebiom.2022.104036_bib0048","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1146\/annurev.me.43.020192.001233","article-title":"Immunologic aspects of schistosomiasis","volume":"43","author":"Capron","year":"1992","journal-title":"Annu Rev Med"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104036_bib0049","doi-asserted-by":"crossref","first-page":"252","DOI":"10.2307\/3282774","article-title":"The ability of fractionated sera from animals vaccinated with irradiated cercariae of Schistosoma mansoni to transfer immunity to mice","volume":"75","author":"Jwo","year":"1989","journal-title":"J Parasitol"},{"issue":"7","key":"10.1016\/j.ebiom.2022.104036_bib0050","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.4049\/jimmunol.136.7.2644","article-title":"Passive transfer with serum and IgG antibodies of irradiated cercaria-induced resistance against Schistosoma mansoni in mice","volume":"136","author":"Mangold","year":"1986","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.ebiom.2022.104036_bib0051","doi-asserted-by":"crossref","first-page":"e290","DOI":"10.1371\/journal.pntd.0000290","article-title":"Elimination of schistosoma mansoni adult worms by rhesus macaques: basis for a therapeutic vaccine?","volume":"2","author":"Wilson","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ebiom.2022.104036_bib0052","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.3389\/fimmu.2020.01246","article-title":"Fifteen years of Sm-p80-based vaccine trials in nonhuman primates: antibodies from vaccinated baboons confer protection in vivo and in vitro from schistosoma mansoni and identification of putative correlative markers of protection","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.ebiom.2022.104036_bib0053","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1007\/s00436-017-5634-4","article-title":"Cross species prophylactic efficacy of Sm-p80-based vaccine and intracellular localization of Sm-p80\/Sm-p80 ortholog proteins during development in Schistosoma mansoni, Schistosoma japonicum and Schistosoma haematobium","volume":"116","author":"Molehin","year":"2017","journal-title":"Parasitol Res"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104036_bib0054","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-3024.1990.tb00933.x","article-title":"Evidence for enhancement of IgGl subclass expression in mice polyvaccinated with radiation-attenuated cercariae of Schistosoma mansoni and the role of this isotype in serum-transferred immunity","volume":"12","author":"Delgado","year":"1990","journal-title":"Parasite Immunol"},{"issue":"7\u20138","key":"10.1016\/j.ebiom.2022.104036_bib0055","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-3024.2005.00764.x","article-title":"Immunity induced by the radiation-attenuated schistosome vaccine","volume":"27","author":"Hewitson","year":"2005","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.ebiom.2022.104036_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2021.106033","article-title":"Heat-killed Propionibacterium acnes augment the protective effect of 28-kDa glutathione S-transferases antigen against Schistosoma mansoni infection","volume":"222","author":"Lam","year":"2021","journal-title":"Acta Trop"},{"issue":"11","key":"10.1016\/j.ebiom.2022.104036_bib0057","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1002\/eji.1830211106","article-title":"Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels","volume":"21","author":"Rihet","year":"1991","journal-title":"Eur J Immunol"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104036_bib0058","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1128\/IAI.00012-09","article-title":"Immunoglobulin E (IgE) responses to paramyosin predict resistance to reinfection with Schistosoma japonicum and are attenuated by IgG4","volume":"77","author":"Jiz","year":"2009","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104036_bib0059","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri3632","article-title":"The production and regulation of IgE by the immune system","volume":"14","author":"Wu","year":"2014","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104036_bib0060","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jaci.2012.04.027","article-title":"Generalized urticaria induced by the Na-ASP-2 hookworm vaccine: Implications for the development of vaccines against helminths","volume":"130","author":"Diemert","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104036_bib0061","first-page":"380","article-title":"Ultrastructure of the attack of eosinophils stimulated by blood mononuclear cell products on schistosomula of Schistosoma mansoni","volume":"120","author":"Caulfield","year":"1985","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104036_bib0062","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4269\/ajtmh.1984.33.104","article-title":"Human neutrophil-mediated killing of schistosomula of Schistosoma Mansoni: augmentation by schistosomal binding of eosinophil peroxidase","volume":"33","author":"Jong","year":"1984","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104036_bib0063","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1017\/S0031182000066890","article-title":"Immune evasion by Schistosoma mansoni: loss of susceptibility to antibody or complement-dependent eosinophil attack by schistosomula cultured in medium free of macromolecules","volume":"82","author":"Dessein","year":"1981","journal-title":"Parasitology"},{"issue":"21","key":"10.1016\/j.ebiom.2022.104036_bib0064","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1007\/s00018-010-0345-3","article-title":"Vector-based RNA interference of cathepsin B1 in Schistosoma mansoni","volume":"67","author":"Tchoubrieva","year":"2010","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104036_bib0065","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1590\/S0100-879X1998000100022","article-title":"Interferon gamma is a key cytokine in lung phase immunity to schistosomes but what is its precise role?","volume":"31","author":"Wilson","year":"1998","journal-title":"Braz J Med Biol Res"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104036_bib0066","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4049\/jimmunol.162.1.345","article-title":"Optimal vaccination against Schistosoma mansoni requires the induction of both B cell- and IFN-gamma-dependent effector mechanisms","volume":"162","author":"Jankovic","year":"1999","journal-title":"J Immunol"},{"issue":"13","key":"10.1016\/j.ebiom.2022.104036_bib0067","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1084\/jem.20082292","article-title":"Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses","volume":"205","author":"Gaucher","year":"2008","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104036_bib0068","doi-asserted-by":"crossref","first-page":"7919","DOI":"10.4049\/jimmunol.0803903","article-title":"The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response","volume":"183","author":"Akondy","year":"2009","journal-title":"J Immunol"},{"issue":"16","key":"10.1016\/j.ebiom.2022.104036_bib0069","doi-asserted-by":"crossref","first-page":"8468","DOI":"10.1128\/JVI.00228-07","article-title":"Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells","volume":"81","author":"Kannanganat","year":"2007","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104036_bib0070","first-page":"1","article-title":"T-cell responses following natural influenza infection or vaccination in solid organ transplant recipients","volume":"10","author":"L'Huillier","year":"2020","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.ebiom.2022.104036_bib0071","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188055","article-title":"Distinct T and NK cell populations may serve as immune correlates of protection against symptomatic pandemic influenza A(H1N1) virus infection during pregnancy","volume":"12","author":"Savic","year":"2017","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104036_bib0072","doi-asserted-by":"crossref","first-page":"6792","DOI":"10.1128\/JVI.07172-11","article-title":"Multifunctional CD4 cells expressing gamma interferon and perforin mediate protection against lethal influenza virus infection","volume":"86","author":"Brown","year":"2012","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104036_bib0073","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1084\/jem.20062363","article-title":"Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses","volume":"204","author":"Precopio","year":"2007","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.ebiom.2022.104036_bib0074","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104036_bib0075","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/s41577-021-00642-8","article-title":"Lessons from vaccine-induced immune thrombotic thrombocytopenia","volume":"21","author":"Kelton","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104036_bib0076","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13071-016-1369-9","article-title":"Do schistosome vaccine trials in mice have an intrinsic flaw that generates spurious protection data?","volume":"9","author":"Wilson","year":"2016","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.ebiom.2022.104036_bib0077","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.3389\/fimmu.2021.711650","article-title":"Promising technologies in the field of helminth vaccines","volume":"12","author":"Perera","year":"2021","journal-title":"Front Immunol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422002171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422002171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:15:35Z","timestamp":1762456535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396422002171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":77,"alternative-id":["S2352396422002171"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104036","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742103680.793593983","asserted-by":"object"}]},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A low dose adenovirus vectored vaccine expressing Schistosoma mansoni Cathepsin B protects from intestinal schistosomiasis in mice","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104036"}}